Today, Kraig Biocraft Laboratories announced that its Board of Directors will be contemplating a proposed forward stock split of the company’s common stock. The meeting has been scheduled to take place after the close of the markets on Wednesday, February 18.
Kraig Biocraft Laboratories, Inc. (KBLB), a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.
Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board